Atherosclerosis

Article	Citations
TNF-α/STEARATE INDUCED H3K9/18 HISTONE ACETYLATION AMPLIFIES IL-6 EXPRESSION IN ADIPOCYTES	159
THE MOLECULAR BASIS OF DIFFERENT GENETIC LIPID DISORDERS IN LEBANON	154
CARDIOVASCULAR MORBIDITYAMONG TUBERCULOSIS PATIENTS IN INDIA: A CROSS-SECTIONAL STUDY	118
IMPACT OF CALEBIN-A ON KEY DIABETES-ASSOCIATED GENES	117
ROLE OF PATIENT ADVOCATES IN SECURING APHERESIS ACCESS IN LEBANON	114
Integrative prediction models of gestational diabetes mellitus: Insights from lipidomic profiling	109
Inclisiran as monotherapy compared with placebo or ezetimibe in patients at low to borderline atherosclerotic cardiovascular disease risk: Results from the VICTORION-Mono randomized clinical trial	97
Quantitative data comparing LDL results produced by lipid ultracentrifugation with those calculated by the Sampson equation	94
Antibody functionalized lipoprotein complexes (LPC) including a repolarizing drug for the targeted therapy of atherosclerosis	90
Browning of perivascular adipose tissue during early atherosclerosis progression: A contrast to clinical atherosclerosis	89
Low residence time of exogeneous HDL is associated with preserved renal function in rats treated with HgCl2 and accumulation of HDL-protein in adipose tissue	88
The effect of PCSK9 inhibitor treatment on plasma proteome in patients with and without familial hypercholesterolemia	84
Modulating atherosclerotic plaque formation by targeting the plasminogen receptor Plg-RKT	82
Lp(a) levels in individuals with metabolic-dysfunction associated steatotic liver disease	81
Sex-specific impact of the COVID-19 pandemic on metabolic syndrome prevalence	81
18FDG-pet imaging reveals glycolytic activity as a marker of atherosclerotic disease activity	76
Levels of C5B-9, RGC-32 and SIRT1 in chronic and acute ischemic coronary artery disease	75
Association of traditional cardiometabolic risk factors with atherosclerotic cardiovascular disease in familial hypercholesterolaemia individuals with severe elevation of LDL-cholesterol	74
Rates of atherosclerotic cardiovascular events and their management in a longitudinal cohort of dermatomyositis patients with skin involvement	71
Activated and regulatory T-helpers and blood monocytes in patients with HFPEF and type 2 diabetes mellitus	68
Anti-endoglin monoclonal antibody inhibits the progression of liver sinusoidal endothelial inflammation and fibrosis in metabolic dysfunction-associated steatohepatitis	68
Noninvasive parameters of myocardial work and diastolic myocardial function in the assessment of heart failure with preserved ejection fraction in patients with postinfarction cardiosclerosis	68
Clinical phenotypes of patients with stable coronary artery disease, with or without concomitant COVID-19, based on left ventricular function and cerebral blood flow	59
Doxorubicin promotes atherosclerosis in an apolipoprotein e-deficient mouse model, potentially associated with serpina3n	58
LATENT TB PREVALENCE AMONG DIABETICS: A SYSTEMATIC REVIEW AND META-ANALYSIS	57

COMMUNITY ENGAGEMENT STRATEGY: ENHANCING VACCINE COVERAGE FOR CARDIOMETABOLIC DISEASE CONTROL	56
ELEVEN YEARS FOLLOW-UP OF 1351 YOUNG FH-INDIVIDUALS IN NORWAY	56
Corrigendum to “The correlation between medial pattern of intracranial arterial calcification and white matter hyperintensities” [Atherosclerosis 381 (2023) 117247]	54
Statin use is associated with less ST-elevation versus non-ST-elevation myocardial infarction in a nationwide study	53
Rabies vaccine induced microangiopathy	53
Bivariate relation of vascular health and blood pressure progression during childhood	53
The impact of gene variants on the thickness and softness of the Achilles tendon in familial hypercholesterolemia	49
Carotid ultrasound and coronary calcium for the prediction of incident cardiac disease in asymptomatic individuals: A further step towards precision medicine especially in women?	49
Low stenosis low volume carotid artery atherosclerotic plaque for early HI-LLT prescription in first grade cardiovascular prevention	46
Differences in coronary angiographic findings and outcomes between men and postmenopausal women with chest pain	46
Vascular structural changes in diabetes mellitus patients with chronic kidney disease	44
Circulating large extracellular vesicles from STEMI patients contribute to cardiovascular damage	43
Association between level of depression and coronary heart disease, stroke risk and all-cause and cardiovascular mortality	42
Illness perception in patients with familial hypercholesterolemia	42
Bempedoic acid efficacy and safety in 7,597 non-diabetic patients, with and without metabolic syndrome, from the randomized, placebo-controlled clear outcomes trial	41
“Early detection of cardiovascular risk factors in women following gestational diabetes mellitus: A cohort study”	41
Compensatory metabolic responses in ChREBP-deficient brown adipose tissue	41
Severe hypertriglyceridemia and its correlation with clinical atherosclerosis and pancreatitis investigated in beta-quantification	41
The effect of MMP 9, TIMP-1 on the dynamics of cardiac fibrosis in patients with and without coronary artery disease 2 years after renal denervation	39
Residual risk in coronary artery disease: Insights from an observational study	38
Machine-learning-based models to predict atherogenic index of plasma range using oculomics and clinic variables in KNHANES for assessing the risk of cardiovascular disease	37
Dissecting sexual dimorphism in aortic valve stenosis by proteomics	37
Statin treatment reduces long-term risk of revision surgery following total hip arthroplasty in osteoarthritis patients: A registry-based study	37
Circulating monocyte phenotype: A novel biomarker of atherosclerosis	37
miR-148a-3p: A novel therapeutic candidate modulating angiogenesis and senescence for enhanced myocardial infarction recovery – experimental insights and targets explored	37
Sex differences in the treatment of familial hypercholesterolemia: A systematic review and meta-analysis	36
Rare variants in U2-spliceosome genes are involved in autosomal dominant hypercholesterolemia	35
Comorbidities, frailty, and prognosis in elderly patients with atrial fibrillation and ischemic heart disease: Insights from a tertiary hospital cohort study	34
Risk factors for progressive cardiorenal syndrome in patients with chronic kidney disease: The CRIC study	34
Interplay between epigenetic mechanisms and transcription factors in atherosclerosis	34
The comparative analyses of combined medicine alpha-lipoic acid and zinc with statins in the treatment of dyslipidemia in patients with atherosclerosis	34
Hepatic Cdkal1 deletion regulates HDL catabolism and promotes reverse cholesterol transport	33
Genetic risk score for human serum lipidome and its association with angiographic coronary artery disease	33
Circular decoys sponge miR-21 and miR-146a in senescent vascular cells	33
Effect of APOC3 inhibition with volanesorsen on hepatic steatosis in patients with severe hypertriglyceridemia	32
Possible clinical usefulness of polygenic risk scores among patients with established atherosclerotic cardiovascular disease	31
The role of systemic inflammation in reducing the elasticity of the main arteries in patients with chronic heart failure in combination with obesity	31
IL-21R blockade reduces atherosclerosis development	31
Comparison of cardiovascular prognosis between triglyceride variability and exposure estimate in diabetic patients	31
Antagonism of miR-148a attenuates the progression of atherosclerosis in APOBTGApobec-/-Ldlr+/- mice	31
Methotrexate associated with a lipid core nanoparticle prevented the dilation and dissection of the aortic arch in mice with Marfan syndrome	31
Silencing of PCSK9 by SIRNA-functionalized RHDL as tool to upregulate LDLR expression in hepatocytes	31
Regulation of interleukin 1Β drives endothelial-to-mesenchymal transition of valve endothelial cells in patients with aortic valve sclerosis	30
Laser- mediated thermal angioplasty of occluded artery accompanied by disulphonated aluminum phthalocyanine - mediated photodynamic therapy combined with catheter- based ruthenium-106 brachytherapy	30
Effect of high- intensity extremely low frequency magnetic field on the intermediate stage atherosclerotic plaque remodeling: Monitored by histopathology and color doppler ultrasonography	30
Targeted proteomics and the presence of carotid plaques in subjects at low cardiovascular disease risk	30
Size, fatty acid and protein characterization of different populations of extracellular vesicles obtained by sequential centrifugation. An useful tool to dissect their biological properties?	30
TREM2 macrophages in adipose tissue and cardiovascular risk	30
Age- and gender-specific lipid and lipoprotein levels and percentiles from the Thai National Health Examination Survey (NHES-VI) in Thailand	29
The reliability of coronary artery calcium score in symptomatic patients: Questioning the “power of zero”	29

An upregulation of scube 2 expression in type 2 diabetes mellitus with dyslipidemia	29
Quality of life in older patients with obesity and chronic kidney disease	29
Atherosclerosis in Brazil: An ecological study	29
Lipid profile assessment as a factor of diabetic nephropathy progression	29
Management of significantly elevated lipoprotein(a) in patients without established ASCVD	28
Reversing the functional- and regenerative capacity of senescent endothelial cells by pharmacological reprogramming	28
Assessment of the improvement in perfusion after endovascular intervention by hyperspectral imaging	28
Do triglycerides have an influence on endothelial function detected by Laser Doppler flowmetry?	28
Does the lipoprotein(A) genotype influence the diagnosis of familial hypercholesterolemia?	27
Bioactive lipids and lipoprotein lipase in epicardial adipose tissue from patients with coronary artery disease: Unfolding a missing link	27
Influence of mineral bone disease biomarkers in carotid modeling as a marker of early atherosclerosis in dialysis patients	27
Genome-wide association study on HDL-mediated cholesterol efflux capacity	27
The real experience of reaching an extremely low LDL-C level in high risk patients	26
Associations of the fatty acids with the concentration of antioxidant enzymes in the blood in men with coronary heart disease	26
Sex differences of lipoprotein(a) levels and associated risk of morbidity and mortality by age: The Copenhagen general population study	26
The impact of cholesterol lowering drugs on metabolism and epigenetics	26
Vulnerable atheromatous plaque stabilization using extracorporeal shock wave- mediated sonoporation therapy- assisted HDL and atorvastatin combination therapy	25
Collaboration of clinic and Biobank as an effective model for dyslipidemia research	25
Endothelial ACKR3 drives atherosclerosis by promoting immune cell adhesion to vascular endothelium	25
Effect of B-mode ultrasound- guided extracorporeal low- level focused sonotherapy on early stage atherosclerosis regression using color doppler ultrasonography and histopathology	25
Aging accelerates atherosclerosis development in C57BL/6 mice upon PCSK9 overexpression	25
Sociodemographic determinants of change in cardiovascular health in middle adulthood in a bi-racial cohort	24
Coronary computed tomography angiography-derived endothelial shear stress in myocardial bridging	24
Tetrahydroxystilbene glycoside attenuates endothelial dysfunction and obesity-associated hypertension in obese rats: The role of omentin-1	24
Fgf23 expression increases atherosclerotic plaque burden in male ApoE deficient mice	24
Common perinatal characteristics and adverse obstetric complications leading to overweight in adolescence: Assessment of independent and shared maternal-offspring pathways	24
Caspase 8-dependent inhibition of necroptosis prevents plaque necrotic core formation	24
Editorial board	24
Genetic expression and immunofluorescence mapping of NaV1 highlight potential therapeutic targets in anti-inflammatory treatment of aortic valves stenosis	24
Evolocumab treatment in paediatric patients with homozygous familial hypercholesterolemia: Data from three pooled open-label studies	24
Soluble CD40 receptor is a biomarker of the burden of carotid artery atherosclerosis in subjects at high cardiovascular risk	22
Isolation and culture of murine aortic cells and RNA isolation of aortic intima and media: Rapid and optimized approaches for atherosclerosis research	22
Lp(a) in Argentina: A multicenter study on prevalence and clinical outcomes	22
Beyond quantity: The nonlinear association between HDL cholesterol and coronary atherosclerosis	22
Illuminating the full spectrum of APOE variation	22
Influence of low glycemic index diet on inflammatory state and lipid parameters in patients with atherosclerotic coronary artery disease	22
Statin therapy and lipoprotein(a) levels: A systematic review and meta-analysis	21
Impact of the clinical diagnostic strata of familial hypercholesterolemia on risk stratification among patients with hypercholesterolemia	21
CLINICAL AND GENETIC CHARACTERISTICS OF LATE-ONSET LAL DEFICIENCY IN OMAN	21
Association of thyroid peroxidase antibody with the RNF213 p.R4810K variant in ischemic stroke/transient ischemic attack	21
The value of a negative study	21
Ethnic variations in neutrophil count as predictors of prognosis following acute myocardial infarction	21
Editorial Board	21
Coronary artery calcium: The canary in the coal mine	21
Relationship between stress hyperglycemia and worsening heart failure in patients with significant secondary mitral regurgitation	20
Obesity is associated with coronary artery stenosis independently of metabolic risk factors: The population-based SCAPIS study	20
Transcriptome analysis revealed a two-step transformation of vascular smooth muscle cells to macrophage-like cells	20
Gene set analysis of transcriptomics data identifies new biological processes associated with early markers of atherosclerosis but not with those of osteoporosis: Atherosclerosis-osteoporosis co/multi	20
N-acetylcysteine therapy reduces major adverse cardiovascular events in patients with type 2 diabetes mellitus	20
Repeated measurement of lipoprotein(a): technical versus biological variability	20
The long journey of lipoprotein(a) from cardiovascular curiosity to therapeutic target	19
Metabolomics of aortic valve stenosis: Are aortic valve stenosis and sclerosis different diseases?	19
Association of genetically predicted levels of circulating blood lipids with coronary artery disease incidence	19
Role of fatty acids in the pathogenesis of ß-cell failure and Type-2 diabetes	19
The effect of LPA Thr3888Pro on lipoprotein(a) and coronary artery disease is modified by the LPA KIV-2 variant 4925G>A	19
Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD)	18
Course of the effects of LDL-cholesterol reduction on cardiovascular risk over time: A meta-analysis of 60 randomized controlled trials	18
LAUNCHOF THE FIRSTHOFH AWARENESS DAY: ADDRESSING UNMET NEEDS	18
Sex differences in LDL-C control in a primary care population: The PORTRAIT-DYS study	18
Galectin-9: A novel promoter of atherosclerosis progression	18
ESTABLISHMENT OF ELISA SYSTEM FOR MODIFIED LDLADIPONECTIN COMPLEX	18
Effect of biological sex on human circulating lipidome: An overview of the literature	18
Editorial Board	18
METABOLOMIC ANALYSIS OF KAZAKH PATIENTS WITH METABOLIC SYNDROME BY GC/MS	17
UCSCS IN TREATMENT OF T1DM AND T2DM; A META-ANALYSIS	17
Clinical profile of familial hypercholesterolemia phenotype in adults attended in primary care in a large healthcare area	17
Atherogenic lipidomics profile in healthy individuals with low cardiorespiratory fitness: The HUNT3 fitness study	17
Pigment epithelium-derived factor prevents endothelial dysfunction in early stage of hyperlipidemia by regulating endothelial fatty acid transport	17
ACCURACY OF TROPONIN VALUE IN ELDERLY WITH ACUTE CORONARY SYNDROME	17
COMPUTATIONAL IDENTIFICATION OF SMALL MOLECULES FOR MODULATING ATHEROSCLEROSIS AND NAFLD	17
CARDIO-PROTECTIVE ROLE OF ROSMARINIC ACID ON ISOPRENALINE INDUCED CARDIAC DYSFUNCTION	17
Lysosomal acid lipase (LAL) deficiency alters immune cells distribution in mice and humans	17
Loss of ADAMTS5 promotes vascular calcification via versican/integrin β1/FAK signal	17
FIRST TIME USE OF LOMITAPIDE IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, UAE	17
GENETIC AND BIOCHEMICAL ANALYSIS OF FOUR JAPANESE SEVERE HYPERTRIGLYCERIDEMIA	17
Different plasma biomarker patterns associated with coronary atherosclerosis in low- versus high-risk individuals – an observational cross-sectional study	17
Genetic testing increases the likelihood of a diagnosis of familial hypercholesterolaemia among people referred to lipid clinics: Danish national study	17
Sex differences in efficacy and safety of PCSK9 monoclonal antibodies: A real-world registry	17
Rosuvastatin effect on atherosclerotic plaque metabolism: A subclinical atherosclerosis imaging study with 18F–NaF PET-CT	16
Editorial board	16

Association between progression of coronary artery calcification and development of kidney failure with replacement therapy: Findings from KNOW-CKD study	16
Genetic variants associated with low-density lipoprotein cholesterol and systolic blood pressure and the risk of recurrent cardiovascular disease in patients with established vascular disease	16
Cascade testing for elevated lipoprotein(a) in relatives of probands with familial hypercholesterolaemia and elevated lipoprotein(a)	16
Outcome of severe hypertriglyceridemia in hospital practice. A single centre experience from Singapore	16
Reply to: “Longitudinal studies assessing retinal vascular characteristics in childhood and adolescence must account for ocular growth”	16
Lipoprotein(a) and cardiovascular disease: Make use of the knowledge we have	16
Diet quality, front-of-pack labeling, and lipoprotein particle profiles	16
Effect of combining evolocumab with statin on carotid intraplaque neovascularization in patients with premature coronary artery disease (EPOCH)	16
A novel homozygous variant in GPIHBP1 and familial chylomicronemia syndrome in latin America	15
The role of antiphospholipid antibodies in the onset of myocardial infarction	15
Impact of circulatory microRNA-126 &122 in severity of coronary artery disease correlation with small dense LDL: A case control study	15
Variant-specific LDL-cholesterol patterns and risk of atherosclerotic cardiovascular disease in heterozygous FH: Insights from the Austrian FH-Registry	15
The polycomb repressive complex 2 (PRC2) in macrophages and atherosclerosis	15
Empagliflozin prevents human aortic smooth muscle cells damage induced by cholesterol	15
LDL drives the polarized endothelial secretion of fibronectin through syntaxin-4 and syntaxin-6	15
A novel cardiovascular-kidney-metabolic syndrome mouse model with inducible HFrEF and atherosclerosis	15
The role of antioxidant intake in weight status of children in early adolescence	15
Joint associations of peripheral artery disease and accelerometry-based physical activity with mortality: The Hispanic Community Health Study/Study of Latinos (HCHS/SOL)	15
Association of blood lipid profile with 20-year (2002-2022) incidence of cardiovascular disease: The ATTICA study	15
Validation of site-less strategies and long-distance drone-based delivery and collection system to promote access to innovative treatments for patients with rare or severe dyslipidemias	15
The interplay between lipoprotein(a) and inflammatory markers in atherosclerotic cardiovascular disease (ASCVD): A focus on neutrophil-to-lymphocyte ratio (NLR)	15
Lifestyle and rate of metabolic risk factors in Norwegian patients with a severe mental illness	15
Minigene splicing reporter assay: a high-stake tool for genetic diagnosis in familial hypobetalipoproteinemia	15
Inflammation in COVID-19 is linked to pulmonary embolism and/or vascular tree-in-bud in hospitalized patients. The university hospital of Ioannina COVID-19 Registry, NCT05534074	15
Low dose interleukin 2 expands plasmablasts with a regulatory b cell phenotype post-MI	15
Docetaxel reduces hepatic lipid accumulation and atherosclerosis	15
Dyslipidemia and other metabolic alterations in COPD as well as cardiovascular risk in a latin American hospital.	15
Gender disparities among contemporary patients with acute coronary syndrome: Data from CALLINICUS-hellas registry	15
Predictors of functional and morphological arterial wall properties in patients with increased lipoprotein (a) before and after treatment with proprotein convertase subtilisin-kexin type 9 inhibitors	14
Cardio-psycho-metabolic profile of patients with cardiovascular disease and obesity	14
Heteroplasmy of atherosclerosis-associated mitochondrial DNA mutations and its effects on respiration and viability of cybrids	14
VEGF-A levels and G634c gene polymorphism as a predictor of adverse outcomes in patients with STEMI	14
Analysis of total cholesterol and its association with blood pressure, age and northern experience in men 25-54 years working on rotational shifts in the north	14
LIPC-E97G gain-of-function variant protects from dyslipidemia and atherosclerosis in mice independently of the LDL receptor	14
Post-prandial analysis of fluctuations in the platelet count and platelet activity in patients with the familial chylomicronemia syndrome	14
Investigation of the antioxidant and anti-inflammatory potency of Echinacea angustifolia extract	14
Lipoprotein(a) is a predictor of atherogenesis in patients with COPD	14
Management of hypercolesterolemic subjects at high cardiovascular risk with PCSK9 inhibitors: A “real life” experience in a lipid clinic in sicily	14
Mature natural killer type 2 cells and experimental atherosclerosis	14
Plasma concentrations of apolipoproteins and incident cardiovascular diseases in patients with type 2 diabetes	14
Association of self-reported health and wellbeing indicators with a positive diagnosis for COVID-19. CARTSESIAN-CY study	13
Cardiopulmonary exercise test alterations in young smokers with obesity	13
Treatment of vulnerable plaque using combined high-density lipoprotein and pentostatin- loaded microbubbles- mediated shock wave sonoporation therapy: Evaluation with positron emission tomography imag	13
The condition of the main arteries in patients with chronic heart failure and diabetes mellitus	13
Arterial stiffness and glycometabolic control in older patients with type 2 diabetes	13
The patient will see you now: Patient preferences for lipid clinic reviews in a COVID era	13
Myeloid cannabinoid receptor CB1 deficiency limits macrophage proliferation and atherosclerosis in a sex-specific manner	13
Orbital ischemia syndrome in a patient with carotid artery dissection - Case report	13
Genetic variation in ADAMTS13 are related to vWF levels, atrial fibrillation and cerebral ischemic events	13
High and low levels of serum Sirtuin6 in patients with acute ischemic stroke	13
An innovative berberine formulation is able to improve bbr bioavailability and the lipid and glycemic profile in HFD-fed mice	13
Chronic kidney disease induced atherosclerosis: The regulatory role of mIR-26b	13
Polymorphism of DNA repair genes (APEX1 T444G RS1130409) in obese gout patients in the male population of the trans-baikal territory in Russia	13
Professor Jeremiah Stamler (1919–2022), “Father of Preventive Cardiology”	13
Statin intolerance: What are we overlooking?	13
The ceramide- and phosphatidylcholine- based coronary event risk test2 (CERT2) and cardiovascular mortality in men and women with type 2 diabetes	13
The effect of iatrogenic hypothyroidism on lipoprotein subfractions and serum paraoxonase activity in patients with differentiated thyroid cancer	13
Prevalence and prognostic impact of lipid goal attainment and patient adherence to lowering lipid treatment: Data from community Italian setting	13
Protective effect of niclosamide on calcification of aortic valve interstitial cells and its underlying molecular mechanism	13
Response of lipoproteins to a meal tolerance test in patients with type 2 diabetes and hypertriglyceridemia	13
Epicardial adipose tissue and metabolic markers in dominican type 2 diabetics with preserved cardiac function	13
Diagnosis, treatment and cardiovascular outcomes in homozygous familial hypercholesterolaemia: A sex-specific analysis	13
Polymorphic assessment of proprotein convertase subtilisin/kexin type 9 (PCSK9) variant rs11591147 in coronary artery disease subjects from Pakistan	12
LPA genotypes and haplotypes influence lipoprotein(a) levels but not arterial wall properties, in stable post-coronary event patients with very high lipoprotein(a) levels	12
Pediatric reference values for non-fasting lipids in French-Canadian children	12
Small LDL subfractions are associated with coronary atherosclerosis	12
Positivity of statin-associated muscle symptoms – Clinical index in a hypertensive population candidated to lipid-lowering therapy but not taking statins	12
Granzyme B+ CD4+ T cells associate with an unstable plaque phenotype in advanced human atherosclerosis	12
In patients with cardiovascular disease and heart failure dental state (tooth loss) may exacerbate inflammatory syndrome	12
Assessment of atherosclerotic lesions of the carotid arteries depending on the smoking index in patients with coronary artery disease	12
Associations of carotenoids, vitamin A and mortality: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study	12
Association of parental obesity and body mass index in children of patients with early ischemic heart disease	12
Region-specific lipid markers of human carotid atherosclerosis plaque outcome detected by matrix-assisted laser desorption/ionization mass spectrometry imaging	12
Hospitalization features and mortality rates of very high-risk patients with dyslipidemia in Turkey	12
New method of calculating low density lipoprotein cholesterol using Korea National Health and Nutrition Examination Survey (KNHANES) and its validation	12
Protein alterations in VSMCS reveal a defective repairment capacity in thoracic aortic aneurysm associated to BAV	12
Polygenic risk for future coronary artery disease events in familial hypercholesterolemia	12
P-selectin as a modulator of fibrin clot properties in patients treated with high-dose statins	12
Dietary pattern of elderly people living in the rural area of Mortugaba (BA), Brazil	12
Nutritional approach in paediatric patients with familial hypercholesterolaemia	12
The importance of cascade screening of familial hypercholesterolemia in routine clinical practice	12
Ensemble machine learning for screening cardiovascular diseases in electronic health records	12
Double trouble: Pathogenic LDLR and SCARB1 variants in the same family	12
Insights into homozygous familial hypercholesterolemia in Portugal	11
Alternative LDL cholesterol-lowering strategy versus high-intensity statin strategy in patients with diabetes and ASCVD: An individual patient data meta-analysis from the racing and lodestar trials	11
Splenic TFH cell localisation in atherosclerosis	11
Comparative efficacy and safety of different RNA interference therapeutics in the management of hypertension: A systematic review and network meta-analysis of clinical trials	11
Does carotid intima media thickness have a role in predicting genetic familial hypercholesterolaemia?	11
Long-term metabolic effect of the E97G gain-of-function variant of hepatic lipase in high-fat diet fed C57BL6/J mice	11
Discrepancies in LDL-C estimation: A comparison of Friedewald, Sampson, and Martin-Hopkins equations in high-risk populations	11
Lipid profile and lipoprotein (a) in systemic sclerosis: A systematic review and meta-analysis	11
Individuals with type 2 diabetes have increased coronary plaque burden and plaque progression during 10-year serial coronary CT angiography follow-up	11
Sex differences in atherosclerosis lesions and in the response to RAS inhibition in the ApoE-/- MICE	11
Impact of endothelial dysfunction on prognosis of coronary heart disease patients	11
Genotypic and phenotypic risk factors for atherosclerotic vascular disease in children with familial hypercholesterolemia	11